Demonstrating Clinical Success in Autoimmune Disease Through Safe & Effective B-Cell Reset Strategies
4:15 pm - Tuesday 9th February 2027
- Defining B-cell reset to achieve meaningful disease remission across autoimmune indications
- Highlighting the mechanistic basis of the safety behind Cabaletta’s rese-cel therapy to provide guidance on the development goals for autoimmune disease
